Development of highly potent human monoclonal for RSV immuno-prophylaxis
Ended Project Grant Awarded Last action
- Award ID
- R44AI136272
- Recipient
-
Mapp Biopharmaceutical, Inc. UEI M9V9QTHR1H28
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,473,268
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Funding
-
- $4,613,699.00 Federal
- $859,569.00 Non-federal
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $947,868 | $0 | |
| Amendment | $947,868 | $0 | |
| Amendment | $801,020 | $0 | |
| Amendment | $801,020 | $801,020 | |
| Amendment | $58,549 | $0 | |
| Amendment | $58,549 | $58,549 | |
| Amendment | -$1,175 | $0 | |
| Original award | $1,000,000 | $0 |
Quick answers
Who received award R44AI136272?
R44AI136272 was awarded to Mapp Biopharmaceutical, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 15, 2018.
How much is award R44AI136272 worth?
$5,473,268 has been obligated on R44AI136272: $4,613,699 in federal funding and $859,569 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award